Table 2 Clinicopathologic characteristics of 63 metastatic colorectal cancer (mCRC) patients with BRAF V600E mutation
Characteristic | No. of patients (%) |
|---|---|
Gender | |
 Male | 27 (42.9) |
 Female | 36 (57.1) |
ECOG PS | |
 0 | 47 (74.6) |
 1 | 10 (15.9) |
 2 | 6 (9.5) |
Primary tumor | |
 Right-sided colon | 27 (42.9) |
 Left-sided colon | 19 (30.2) |
 Rectum | 17 (26.9) |
No. of involved organs | |
 1 | 17 (27.0) |
 > 1 | 46 (73.0) |
Liver metastasis | |
 Yes | 29 (46.0) |
 No | 34 (54.0) |
Peritoneal metastasis | |
 Yes | 26 (41.3) |
 No | 37 (58.7) |
Distant lymph node metastasis | |
 Yes | 50 (79.4) |
 No | 13 (20.6) |
Lung metastasis | |
 Yes | 12 (19.0) |
 No | 51 (81.0) |
Mucinous or signet-ring cell component | |
 Yes | 13 (20.6) |
 No | 50 (79.4) |
Differentiation (adenocarcinoma)a | |
Well-moderate | 31 (51.7) |
Poor | 29 (48.3) |